Financials
- Market Capitalization 457.7 M
- Employee 88
- Founded 1994
- CEO Craig A Tooman
- Website www.silence-therapeutics.com
- Headquarter United Kingdom
- FIGI BBG00WVTHPN2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.76
ratio cours/chiffre d'affaires
890.06
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2965 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.55 USD | -3.73% | -20.10% | -6.63% | -25.48% | 468.19 M USD | ||
| 2969 | RZLT Rezolute, Inc. - Common Stock | 4.75 USD | -1.66% | -4.43% | +9.20% | -6.86% | 457.39 M USD | ||
| 2978 | OVID Ovid Therapeutics Inc. - Common Stock | 2.46 USD | 0.00% | -8.21% | +9.33% | +583.33% | 459.13 M USD | ||
| 2989 | PRTA Prothena Corporation plc - Ordinary Shares | 8.59 USD | -0.58% | -11.08% | +5.27% | +37.00% | 449.71 M USD |